ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2,2,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
4,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
5,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
6,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8,8,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8,10,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
13,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
13,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
15,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
15,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
15,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
15,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
17,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
17,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
17,5,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
17,6,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
17,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
17,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
19,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
19,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
20,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
21,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
22,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
22,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
22,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
22,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
22,7,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
22,8,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
22,9,Non-small cell lung cancer metastatic,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
22,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
23,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
24,1,Alopecia scarring,Alopecias,Skin appendage conditions,Skin,N
24,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
24,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
24,4,Pyoderma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
24,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,6,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
24,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
25,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
25,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
25,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
26,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
27,1,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
28,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
29,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
30,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
30,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
30,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
31,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
31,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
32,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
33,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
33,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
35,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
37,1,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
37,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
37,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
38,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
39,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
40,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
40,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
40,3,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
40,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
40,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
41,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
42,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
43,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
43,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
44,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
44,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
45,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
45,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,2,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
46,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
47,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
47,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
47,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
48,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
50,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
50,4,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
50,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
51,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
52,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
53,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
55,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,2,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
56,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
57,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
58,1,Choroid melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
58,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
58,3,Serous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
59,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
60,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
60,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
60,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
60,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
61,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
61,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
61,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
62,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
62,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
63,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
63,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
63,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
63,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
64,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
65,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
65,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
66,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
66,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
66,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
67,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
68,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
68,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
68,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
68,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
68,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
69,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
72,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
74,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
74,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
75,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
75,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
76,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
76,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
77,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
78,2,EGFR gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
78,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
78,4,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
78,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
79,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
79,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
79,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
79,4,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
79,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
79,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,7,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
80,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
80,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
80,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
81,2,Anisocoria,Pupil disorders,Ocular neuromuscular disorders,Eye,N
81,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
81,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
81,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
81,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
81,8,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
81,9,Genital injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
81,10,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
81,11,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
81,12,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
81,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,14,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
81,16,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
81,17,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,18,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
81,19,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
81,20,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
82,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
82,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
82,3,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
82,4,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
82,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
82,7,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
83,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
83,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
85,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
85,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
85,5,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
86,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
86,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
88,1,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
88,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
89,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
90,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
90,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
90,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
90,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
90,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
90,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
90,7,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
90,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
90,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
91,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
91,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
91,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
91,5,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
92,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
92,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
92,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
92,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,6,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
92,7,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
92,8,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
92,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
92,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
93,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
93,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
93,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,4,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
94,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
94,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
94,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,Y
94,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,1,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
95,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
96,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
96,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,1,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
99,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
99,2,Blood uric acid decreased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
99,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
99,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
99,5,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
100,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
101,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
102,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
102,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
102,3,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,Y
102,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
103,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
103,3,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
103,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
105,1,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
106,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
106,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
106,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
106,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
107,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
107,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,3,Drug resistance mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
107,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
107,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
107,6,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
107,7,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
107,8,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
108,1,EGFR gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
108,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
108,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
108,5,Metastases to pleura,Metastases to specified sites,Metastases,Neopl,N
108,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
110,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
111,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
112,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
113,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
